Healthspan is the part of your life spent in good health, free of serious chronic disease or disability. Lifespan is total years lived, whatever your health during them. In the UK those two numbers sit about 18 years apart for men and 22 years apart for women. That difference is the foundation of longevity science. Living longer and living well for longer are separate goals, reached by different means, and one doesn’t follow from the other.
- Lifespan measures total years lived. Healthspan measures the years lived in good health.
- Modern medicine has extended lifespan faster than healthspan in many populations.
- UK healthy life expectancy is 60.7 years for men and 60.9 years for women, against a life expectancy of 79.1 and 83.0 years (ONS, 2022 to 2024).
- More years are now spent with chronic disease or disability than in previous generations.
- Healthspan is generally the more actionable, immediate target for day-to-day decisions.
The growing gap between the two
Public health data across developed countries shows the same pattern. Average lifespan rose sharply over the past century, thanks largely to sanitation, vaccination and acute medical care. Healthspan hasn’t kept pace. The practical result is that a growing share of total lifespan is spent managing one or more chronic conditions, particularly in the later decades. Earlier increases in lifespan implicitly promised those years would be disease-free.
The UK numbers are blunt. ONS put healthy life expectancy at birth at 60.7 years for men and 60.9 years for women in 2022 to 2024, against a life expectancy of 79.1 and 83.0 years. That leaves 18.4 years for men and 22.1 years for women lived in less than good health. These are population estimates at birth rather than a forecast for any individual, and the healthy years you have left at 50 are more than simple subtraction suggests.
The reason is survivorship. An at-birth figure is dragged down by everyone who died or fell ill young. Reach 65 in good health and you have already avoided most of that, so your remaining expectancy is higher than subtracting your age from the headline number implies. ONS puts life expectancy at 65 at 18.7 years for males and 21.2 for females in 2022 to 2024, which is more than the at-birth figures minus 65.
The same correction applies to the healthy years. ONS publishes healthy life expectancy at 65 in the datasets accompanying the bulletin, and it is the figure to look up if you are already past that age, because subtracting from the at-birth number will understate what you have left.
The direction of travel is the part worth worrying about. UK healthy life expectancy has fallen to its lowest level since the ONS series began in 2011 to 2013. Against 2019 to 2021 it dropped by 1.8 years for males and 2.5 years for females.
Over the same period lifespan held broadly steady. Female life expectancy has returned to its 2017 to 2019 level and male life expectancy remains slightly below it, so this is not a recovery so much as a plateau. The contrast still stands: healthspan is falling while lifespan is not.
You will also see the gap quoted at around a decade, and that figure isn’t wrong either. The clearest way to see why is to hold the country constant. On the WHO health-adjusted method, the UK gap is 11.3 years. On the ONS self-reported method, over the same period, it is 18.4 years for men and 22.1 for women.
Same country, same years, roughly double the answer. WHO weights each year by the severity of the condition, so a mild problem costs a fraction of a year. ONS asks people to rate their own general health and counts anything below "good" as unhealthy. One phenomenon, two measuring sticks.
Women live longer and spend more of it unwell
Look again at the UK figures. Women live nearly four years longer than men, 83.0 against 79.1. Their healthy life expectancy is 60.9 against 60.7, which is effectively the same number.
Almost every extra year women live is a year in less than good health.
ONS puts it proportionally, which is easier to hold onto: men are expected to spend 77% of life in good general health, women 73%. That framing has the advantage of not requiring you to know the base.
This is not a UK quirk. Garmany and Terzic, examining all 183 WHO member states, found women's healthspan–lifespan gap averaging 2.4 years wider than men's, associated with a disproportionately larger burden of non-communicable disease.
What is actually driving the UK decline
The instinct is to assume this is about old people getting sicker. It isn't.
Over the decade from 2012–14 to 2022–24, UK healthy life expectancy fell from 62.9 to 60.7 years for males and from 63.7 to 60.9 for females, while life expectancy at birth stayed broadly stable. Mortality is not what changed.
Health Foundation analysis of the ONS data isolates where it did. If self-reported health among 25-to-49-year-olds in 2022–24 had matched 2012–14 levels, healthy life expectancy would be 1.4 years higher for males and 1.5 years for females.
Deteriorating health among working-age adults is doing most of the work. That is a different problem from an ageing population, and it responds to different things.
Where the US sits
The figures above are UK-anchored, and a US reader has one striking comparative fact available. In the Garmany and Terzic analysis of 183 countries, the United States recorded the largest healthspan–lifespan gap of any member state, alongside the greatest burden of non-communicable disease.
For context on the range, the UK sits at 11.3 years on that same measure and Norway at 11.2.
That gap is the central problem much of modern longevity science is trying to address, including the "hallmarks of aging" framework. The aim isn’t more years. It's closing the distance between total years and healthy ones.
Why healthspan is the more actionable target
Directly engineering a longer lifespan is hard to act on day to day. It's a distant outcome, difficult to measure, and shaped by countless things outside your control.
Healthspan is different. It's built from markers you can measure and influence now: body composition, cardiovascular fitness, strength and functional capacity. Each responds to known behavioural levers over months rather than decades.
Not all of it is down to you. Men in the most deprived areas of England had a healthy life expectancy of 49.8 years in 2022 to 2024, against 69.2 years in the least deprived areas. Measured across the whole deprivation scale, the spread was 19.3 years for healthy life expectancy and 10.4 years for total life expectancy. Healthspan varies about twice as much as lifespan by circumstance, which is a reason to work on what you control rather than a reason to think it is all in your hands.
Geography compounds it. Measured as the spread between local areas, from the 2.5th to the 97.5th percentile, the range was 14.7 years for males and 15.8 for females in 2022 to 2024, and spatial inequality has widened since the pandemic. Within England the South East is highest at 63.0 years for males and 64.3 for females, the North East lowest at 57.0 and 56.9, and it has been lowest in every period since the series began. Across the UK nations, England is highest for both sexes at 60.9 and 61.3, Scotland lowest for males at 59.1, and Wales lowest for females at 58.5.
Those are three different measurements and they produce three different numbers, so they are worth keeping apart rather than blending into one statistic about inequality.
One figure makes the abstraction concrete. In 2022 to 2024, male healthy life expectancy was below the state pension age of 66 in 204 of 216 UK local areas, 94% of them, and female healthy life expectancy in 197 of 216, 91%. That is Health Foundation analysis of the ONS data, and it means most people in most places can expect to stop being healthy before they stop working.
How healthspan is measured
Lifespan is trivial to measure: one date subtracted from another. Healthspan has no equivalent, and that isn’t a minor technicality. It's why estimates of the gap vary so widely between sources, and why you should treat any single confident number with suspicion.
Three approaches dominate, and they answer subtly different questions.
- Health-adjusted life expectancy (HALE). The WHO measure. It takes total life expectancy and discounts years lived with illness or disability by their severity, producing a single figure of equivalent years in full health. It's the most widely used and the most abstract.
- Disability-free life expectancy. Counts years until a person can no longer perform defined activities of daily living without help. More concrete than HALE, and more sensitive to where you draw the line on disability.
- Disease-free life expectancy. Counts years until first diagnosis of a major chronic condition. The cleanest to compute from medical records, and the most affected by screening intensity: diagnose earlier and healthspan appears to shorten, though nothing about the person has changed.
Screening intensity deserves attention because it distorts trend data. A population that screens aggressively for diabetes and hypertension will record more disease-years than an identical population that doesn’t, purely as an artefact of detection. Comparisons across countries and across decades run into that problem constantly.
Why measuring function works better
None of the three works for an individual. All three are population statistics computed in retrospect, and you can’t know your own disability-free life expectancy in advance. What you can measure is the underlying capacity that decides whether you'll stay functionally independent: cardiorespiratory fitness, grip strength, and the sit-to-stand test.
Those three are proxies rather than healthspan itself, and worth treating that way. But they move in response to what you do, and you can measure them this week. The associations with later independence are well documented. A number you can act on beats a more elegant one you can’t.
How to run the two you can do at home
Grip strength. Measured with a handheld dynamometer, which costs about the same as a cheap kettlebell. Sit with your elbow at ninety degrees and tucked to your side, wrist neutral. Squeeze as hard as you can for three to five seconds. Take three attempts per hand with a short rest between, and record the best single reading from your dominant hand. Consistency of position matters more than which protocol you pick, because you are tracking your own trend. Norms are banded by age and sex, and the grip strength entry covers them.
Five-times sit-to-stand. Use a standard dining chair, roughly 43 to 45cm seat height, against a wall so it cannot slide. Sit with your arms folded across your chest, feet flat. Stand fully upright and sit back down five times as quickly as you safely can, and record the time in seconds from the moment you start to the moment you sit after the fifth repetition. Arms stay folded throughout: pushing off the thighs makes the result incomparable. The sit-to-stand entry covers the scoring bands and the related floor-based version.
Both are age- and sex-banded, so a raw number means little until you read it against your own group. Retest quarterly rather than weekly, since these move over months.
What actually moves healthspan
Plenty of things are marketed as extending healthspan. One of them has an evidence base that matches the claim.
Physical activity has by far the strongest human evidence of any intervention here, and the gap between it and everything else is not close. It is the only lever with decades of outcome data across large populations, rather than mechanistic plausibility or short trials measuring surrogate markers.
The useful detail is that the two kinds of training protect different things. Cardiorespiratory work builds the aerobic capacity that decides how much reserve you have for everyday demands. Resistance training preserves the muscle and strength that decide whether you can get off the floor unaided at eighty. Neither substitutes for the other, and programmes that do both outperform programmes that pick one.
On supplements, the honest position is that the share of attention the category receives does not match the share of evidence it has produced. Some compounds correct a measured deficiency, which is a real and worthwhile thing to do. Very few have human outcome data of the kind physical activity has, and none has been shown to extend healthspan in people.
That is an unglamorous answer. It is also the one the evidence supports, and it is why the markers above are the ones worth tracking: they respond to the intervention that works.
Healthspan vs. lifespan, side by side
| Lifespan | Healthspan | |
|---|---|---|
| Measures | Total years lived | Years lived in good health |
| UK men (ONS, 2022 to 2024) | 79.1 years | 60.7 years |
| UK women (ONS, 2022 to 2024) | 83.0 years | 60.9 years |
| Actionability | Hard to directly influence | Responds to trackable, near-term behaviours |
| Historical trend | Increased substantially | Increased more slowly, and falling in the UK since 2011 to 2013 |
How the two scores are built
The gap between the two is only useful if you can see it. Longevity Coach IQ scores them separately. Both come from the same marker set and the same scoring model, filtered by what each marker's research predicts.
| Evidence base | Counts toward | Examples |
|---|---|---|
| Mortality or disease risk | Lifespan | Blood pressure, ApoB, HbA1c, waist-to-height ratio, fasting glucose |
| Functional capacity or quality of life | Healthspan | Grip strength, cognition, protein intake, step test recovery |
| Substantial evidence on both | Both | VO2 Max, compound strength, gait speed, single-leg balance |
Some markers belong in both columns. A marker like VO2 Max is a genuine measure of functional fitness and a validated mortality predictor in its own cited research, so forcing it into one column would misrepresent the evidence. It counts toward both.
Smoking, drinking and a diabetes diagnosis apply to Lifespan only. The research behind all three is mortality-focused, so that is the only place an honest effect belongs. Splitting the score that way is useful rather than decorative. Someone fit who smokes sees a strong Healthspan number next to a materially lower Lifespan one, and a single blended score would hide exactly that gap.
The full assignment logic, marker by marker, is set out on the methodology page, and the reference data each marker is scored against is listed under benchmark sources. If this section is convincing, those are the places to check it.
Which number to work on
The wellness industry uses "longevity" loosely, often implying lifespan extension without saying so. Set your own goals against healthspan markers instead. Those are the ones that answer to what you actually do.
Then retest them on a schedule. A grip strength or VO2 Max figure that has moved is real feedback you can act on. An abstract lifespan estimate gives you nothing to compare against.
Longevity Coach IQ scores Healthspan and Lifespan as two separate numbers, each built only from the markers whose evidence supports it.
Sources
Key references for the claims on this page. Where a figure is attributed to a specific study or body, it is named here.
- Garmany A, Terzic A. Global healthspan-lifespan gaps among 183 World Health Organization member states. JAMA Netw Open. 2024;7(12):e2450241. Source of the 9.6-year global mean gap, the 2.4-year sex difference, the 6.5 against 5.4 year divergence, the UK figure of 11.3 years and the finding that the United States has the largest gap of any member state. DOI
- Office for National Statistics. Healthy life expectancy, UK: between 2011 to 2013 and 2022 to 2024. Source of the 60.7 and 60.9 year figures, the falling trend, the 77% and 73% proportions, the 1.8 and 2.5 year decreases, and the local-area spread. Read at ONS
- Office for National Statistics. National life tables, UK: 2022 to 2024. Source of the 79.1 and 83.0 year life expectancy figures, and the at-65 figures of 18.7 and 21.2 years. Read at ONS
- Office for National Statistics. Healthy life expectancy by national area deprivation, England and Wales. Source of the 49.8 and 69.2 year figures and the inequality spreads. Read at ONS
- The Health Foundation. Analysis of ONS healthy life expectancy data. Source of the working-age contribution to the decline, the 1.4 and 1.5 year figures, and the state pension age comparison across 216 local areas. Health Foundation
- Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. npj Regenerative Medicine. 2021;6:57. Covers the definitional problem in measuring healthspan. DOI
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. The framework referenced above. The same authors published an updated version in Cell in 2023. DOI
- Fries JF. Aging, natural death, and the compression of morbidity. New England Journal of Medicine. 1980;303(3):130–135. The original statement of the compression hypothesis. DOI
- Crimmins EM, Beltrán-Sánchez H. Mortality and morbidity trends: is there compression of morbidity? Journals of Gerontology Series B. 2011;66(1):75–86. Found length of life with disease and mobility loss increasing rather than compressing. DOI
Frequently asked
What's the difference between healthspan and lifespan?
Lifespan is total years lived. Healthspan is the years lived in good health specifically, a distinct measure.
Can you extend lifespan without extending healthspan?
Yes, and it happens more often than people appreciate. More years are now spent with chronic disease than in previous generations.
Why focus on healthspan rather than lifespan?
The markers you track are direct drivers of daily function. That makes healthspan a more actionable and immediate goal than an abstract lifespan target.
How is healthspan actually measured?
There's no single agreed definition, which is the honest answer. Researchers use proxies: years lived free of chronic disease, years without disability, or years of preserved functional capacity. Each produces a different number for the same population. That ambiguity is why Longevity Coach IQ builds its Healthspan score from markers whose own evidence base is functional capacity, rather than estimating a number of healthy years.
How big is the gap between healthspan and lifespan?
It depends entirely on which measure you use, and the clearest way to see that is to hold the country constant. For the UK, the WHO health-adjusted method puts the gap at 11.3 years. The ONS self-reported method, over the same period, puts it at 18.4 years for men and 22.1 for women. Same country, same years, roughly double the answer. The direction of travel is the reliable part: the two have been pulling apart, and UK healthy life expectancy is now falling.
Does anything reliably extend healthspan in humans?
Regular physical activity has by far the strongest evidence base, particularly the combination of cardiorespiratory training and resistance work. No supplement comes close. That's unglamorous, which is probably why so much of the longevity market points you towards supplements instead, but the evidence isn’t evenly balanced between the two.
If I only had time for one thing, what would move healthspan most?
Cardiorespiratory fitness, measured as VO2 Max, is the marker most consistently tied to both mortality and functional independence. Strength runs a close second and matters more for the specific question of staying independent. If you can only train one quality, train the one your own scores say is furthest behind.
Does a longer healthspan mean a sudden death at the end?
Not necessarily. The idea that illness compresses into a short window before death is a specific hypothesis called compression of morbidity, and whether it actually happens at population level is still contested. Improving your healthspan improves the years you're living through, regardless of how the final period plays out. Fries proposed it in 1980; Crimmins and Beltrán-Sánchez, examining the trend data three decades later, found length of life with disease and mobility loss increasing rather than compressing. It remains a hypothesis about the shape of the end of life rather than a guaranteed outcome.